<DOC>
	<DOCNO>NCT03058601</DOCNO>
	<brief_summary>Cohort study use data Clinical Practice Research Datalink ( CPRD ) . The study cohort include patient receive least one prescription ticagrelor first time December 2010 March 2015 , follow ACS . Patient baseline characteristic describe : ( Age , Gender , Body Mass Index , Smoking status , Sociodemographic status ) , type ACS intervention , CV history comorbidities , bleed respiratory history . The following outcome examine : Incidence vascular event ( composite MI , Stroke , vascular death , specific vascular event cause death ) , incidence bleed incidence dysponea . Time event vascular event , bleed dyspnoea .</brief_summary>
	<brief_title>Outcomes UK ACS Patients Prescribed Ticagrelor</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>First prescription ( index date ) ticagrelor Dec 2010 Mar 2015 At least 12 month history database prior first ticagrelor prescription Linkage Hospital Episode Statistics ( HES ) Acute Coronary Syndrome ( ACS ) event three month prior include index date Primary care prescription clopidogrel prasugrel ACS date index date</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>